Knight Therapeutics (TSE:GUD) Shares Up 0.2% – Here’s What Happened

Shares of Knight Therapeutics Inc. (TSE:GUD) were up 0.2% on Thursday . The stock traded as high as C$6.09 and last traded at C$6.05. Approximately 20,473 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 60,403 shares. The stock had previously closed at C$6.04.

Knight Therapeutics Price Performance

The firm has a market capitalization of C$600.70 million, a PE ratio of -151.25, a P/E/G ratio of -1,013.50 and a beta of 0.06. The company has a debt-to-equity ratio of 7.52, a current ratio of 3.36 and a quick ratio of 1.79. The business’s 50 day moving average is C$5.95 and its two-hundred day moving average is C$6.06.

Knight Therapeutics (TSE:GUD) last issued its quarterly earnings results on Thursday, November 6th. The company reported C($0.04) EPS for the quarter. Knight Therapeutics had a negative return on equity of 4.04% and a negative net margin of 8.81%.The company had revenue of C$122.63 million during the quarter. As a group, research analysts anticipate that Knight Therapeutics Inc. will post 0.1009486 EPS for the current year.

Knight Therapeutics Company Profile

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company’s principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets.